OLA ABUHAMDEH: Open Payments
NPI 1255010526 · AVON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,875 in 207 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $1,031 · 2025 $3,875
Food & beverage: $3,875
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $588 |
| ABBVIE INC. | 32 | $486 |
| Lilly USA, LLC | 19 | $457 |
| UCB, Inc. | 20 | $388 |
| Organon LLC | 14 | $328 |
| GENZYME CORPORATION | 7 | $250 |
| Novartis Pharmaceuticals Corporation | 14 | $196 |
| Regeneron Healthcare Solutions, Inc. | 8 | $168 |
| PFIZER INC. | 11 | $161 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $140 |
Products named: TREMFYA, Bimzelx, EBGLYSS, SKYRIZI, DUPIXENT, VTAMA, CIBINQO, OPZELURA.
Industry payments across OH — which companies pay providers there.
